Crossmark

Population-wide administration of single dose rifampicin for leprosy prevention in isolated communities: a three year follow-up feasibility study in Indonesia

Crossref DOI link: https://doi.org/10.1186/s12879-018-3233-3

Published Online: 2018-07-11

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tiwari, Anuj http://orcid.org/0000-0003-4819-2905
Dandel, Steaven

Djupuri, Rita

Mieras, Liesbeth

Richardus, Jan Hendrik
Funding

Funding for this research was provided by:

Novartis Foundation
License Information

Text and Data Mining valid from 2018-07-11
More Information

Article History

Received: 21 September 2017

Accepted: 3 July 2018

First Online: 11 July 2018

Ethics approval and consent to participate

: Ethics approval not applicable. Post exposure prophylaxis with single dose of rifampicin is a routine strategy under National Leprosy Control Program (NLCP) of Indonesia. The study was conducted as a routine monitoring and evaluation activity of NLCP. A verbal consent was taken from all the participants, and from parents in case of minors. The information on refused consent is shown in Table InternalRef removed.

: A verbal consent was taken from all the participants and data on declined consent were reported in the result section.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below